Thurman JM - Search Results

1

Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction.

Girardi G, Yarilin D, Thurman JM, Holers VM, Salmon JE. Girardi G, et al. Among authors: thurman jm. J Exp Med. 2006 Sep 4;203(9):2165-75. doi: 10.1084/jem.20061022. Epub 2006 Aug 21. J Exp Med. 2006. PMID: 16923853 Free PMC article.

2

Lack of a functional alternative complement pathway ameliorates ischemic acute renal failure in mice.

Thurman JM, Ljubanovic D, Edelstein CL, Gilkeson GS, Holers VM. Thurman JM, et al. J Immunol. 2003 Feb 1;170(3):1517-23. doi: 10.4049/jimmunol.170.3.1517. J Immunol. 2003. PMID: 12538716

3

Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome.

Girardi G, Berman J, Redecha P, Spruce L, Thurman JM, Kraus D, Hollmann TJ, Casali P, Caroll MC, Wetsel RA, Lambris JD, Holers VM, Salmon JE. Girardi G, et al. Among authors: thurman jm. J Clin Invest. 2003 Dec;112(11):1644-54. doi: 10.1172/JCI18817. J Clin Invest. 2003. PMID: 14660741 Free PMC article.

4

The alternative pathway of complement in disease: opportunities for therapeutic targeting.

Holers VM, Thurman JM. Holers VM, et al. Among authors: thurman jm. Mol Immunol. 2004 Jun;41(2-3):147-52. doi: 10.1016/j.molimm.2004.03.012. Mol Immunol. 2004. PMID: 15159060 Review.

5

A novel inhibitor of the alternative complement pathway prevents antiphospholipid antibody-induced pregnancy loss in mice.

Thurman JM, Kraus DM, Girardi G, Hourcade D, Kang HJ, Royer PA, Mitchell LM, Giclas PC, Salmon J, Gilkeson G, Holers VM. Thurman JM, et al. Mol Immunol. 2005 Jan;42(1):87-97. doi: 10.1016/j.molimm.2004.07.043. Mol Immunol. 2005. PMID: 15488947

6

Acute tubular necrosis is characterized by activation of the alternative pathway of complement.

Thurman JM, Lucia MS, Ljubanovic D, Holers VM. Thurman JM, et al. Kidney Int. 2005 Feb;67(2):524-30. doi: 10.1111/j.1523-1755.2005.67109.x. Kidney Int. 2005. PMID: 15673300 Free article.

7

The central role of the alternative complement pathway in human disease.

Thurman JM, Holers VM. Thurman JM, et al. J Immunol. 2006 Feb 1;176(3):1305-10. doi: 10.4049/jimmunol.176.3.1305. J Immunol. 2006. PMID: 16424154 Review.

8

Altered renal tubular expression of the complement inhibitor Crry permits complement activation after ischemia/reperfusion.

Thurman JM, Ljubanović D, Royer PA, Kraus DM, Molina H, Barry NP, Proctor G, Levi M, Holers VM. Thurman JM, et al. J Clin Invest. 2006 Feb;116(2):357-68. doi: 10.1172/JCI24521. Epub 2006 Jan 26. J Clin Invest. 2006. PMID: 16444293 Free PMC article.

9

Treatment with an inhibitory monoclonal antibody to mouse factor B protects mice from induction of apoptosis and renal ischemia/reperfusion injury.

Thurman JM, Royer PA, Ljubanovic D, Dursun B, Lenderink AM, Edelstein CL, Holers VM. Thurman JM, et al. J Am Soc Nephrol. 2006 Mar;17(3):707-15. doi: 10.1681/ASN.2005070698. Epub 2006 Feb 8. J Am Soc Nephrol. 2006. PMID: 16467447

10

Pharmacological complement inhibition at the C3 convertase level promotes neuronal survival, neuroprotective intracerebral gene expression, and neurological outcome after traumatic brain injury.

Leinhase I, Schmidt OI, Thurman JM, Hossini AM, Rozanski M, Taha ME, Scheffler A, John T, Smith WR, Holers VM, Stahel PF. Leinhase I, et al. Among authors: thurman jm. Exp Neurol. 2006 Jun;199(2):454-64. doi: 10.1016/j.expneurol.2006.01.033. Epub 2006 Mar 20. Exp Neurol. 2006. PMID: 16545803

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

172 results

Search Page

Filters